Latest News
Optibiotix names René Kamminga as CEO of subsidiary
Biotechnology company Optibiotix Health named René Kamminga as chief executive officer of its OptiBiotix Ltd subsidiary on Tuesday, subject to completion of normal regulatory due diligence.
FCA warns of rise in young investors engaging in high-risk transactions
The Financial Conduct Authority published findings on Tuesday that show how young investors are increasingly engaging in high-risk transactions such as cryptocurrencies and foreign exchange.
Roche-Regeneron antibody treatment cuts Covid deaths
A cocktail of antibodies developed by Roche and Regeneron Pharmaceuticals to treat Covid-19 has been shown to cut hospitalisation or death by 70%, the Swiss drugmaker said on Tuesday.
Pharmacovigilance drives growth at Ergomed
Pharmaceutical services company Ergomed reported a 26. 5% increase in revenue in its full-year results on Tuesday, to £86. 4m.
Profits slide at McColl's despite Covid sales boost
McColl’s Retail Group reported a slide in annual earnings on Tuesday, despite a surge in demand caused by the Covid-19 pandemic.
Fed's Kaplan among those expecting first interest rate hike in 2022
The US central bank should start hiking interest rates in 2021, a top Federal Reserve official reiterated on Tuesday.
MP Evans profit surges after record year of palm oil production
Indonesian palm oil producer MP Evans reported profit of $22. 2m (£16. 09m) in its final results on Tuesday, up from$7. 5m year-on-year.
US pre-open: Futures lower on first anniversary of Covid-19 sell-off
Wall Street futures were in the red ahead of the bell on Tuesday, twelve months to the day that the Covid-19 pandemic bull market began and stocks tumbled 30% at the fastest pace in history.
Revenue rises in pandemic year at Mortgage Advice Bureau
Mortgage Advice Bureau reported a 3% improvement in full-year revenue on Tuesday, to £148. 3m, which included £14. 7m of revenue generated by First Mortgage Direct.
UK manufacturing whirs back to life in March, despite headwinds
Britain's factories are whirring back to life with activity expected to accelerate rapidly over the next quarter, the results of a closely-followed survey revealed.
London midday: Stocks maintain losses as third wave concerns, travel ban weigh
London stocks were still a little lower by midday on Tuesday, with travel and leisure issues under pressure ahead of tighter border restrictions, while concerns about a third coronavirus wave in Europe and tensions between China and the West also weighed on sentiment.
Pfizer to research using mRNA technology against other viruses
Pfizer will strike out on its own to develop vaccines against viruses other than SARS-CoV-2 using the the same mRNA technology used against the novel coronavirus.
Volvo warns over global chip shortage, shares slide
Swedish truckmaker Volvo Group has warned that the global semiconductor shortage will hit production this year, denting earnings.
Consumers shift spending habits to local stores during pandemic
Consumer spending declined 7. 1% in 2020 due to the restrictions caused by the pandemic with buyers turning to local stores for their purchases.
Berenberg raises target price on Taylor Wimpey
Analysts at Berenberg raised their target price on construction firm Taylor Wimpey from 180. 0p to 210. 0p on Tuesday, citing continued momentum across the group.
Europe midday: Fears new lockdowns will stall recovery hits shares
European shares remained lower at midday on Tuesday after Germany confirmed an extended lockdown into Easter as it tried to combat the third wave of Covid-19 infections currently spreading across the Continent, sparking fears of a delay to economic recovery.
Abu Dhabi sovereign fund invests $150m in Telegram app
Abu Dhabi state fund Mubadala Investment and Abu Dhabi Catalyst Partners, part-owned by Mubadala, announced on Tuesday they had made a combined investment of $150m in messaging app Telegram.
Biome secures contractual commitment with US customer
Bioplastics and radiofrequency technology company Biome Technologies has secured an expected contractual commitment with a second US end-customer, it announced on Tuesday, to accelerate the commercialisation of its proprietary compostable filtration material.
First-half losses widen in Amte's first results since IPO
Specialist lithium and sodium battery developer Amte Power reported revenue of £0. 62m in its first half on Tuesday, rising from £0. 58m year-on-year.
RBC upgrades Bunzl after de-rating, 'robust' FY results
RBC Capital Markets lifted its stance on Bunzl shares on Monday to ‘sector perform’ from ‘underperform’ and upped the price target to 2,270p from 2,200p following a de-rating.